Medtronic director gets 2,111-share RSU award

Medtronic plc director Kevin E. Lofton reported routine equity compensation activity involving Ordinary Shares.

Rhea-AI Filing Summary

Medtronic plc director Kevin E. Lofton reported routine equity compensation activity involving Ordinary Shares. On April 27, 2026, he acquired 2,111 shares at $0.00 per share as a grant of restricted stock units that vest on the one-year anniversary of the award date.

On April 28, 2026, 207 shares were withheld at $81.90 per share to cover taxes upon vesting of previously reported restricted stock units, a tax-withholding disposition rather than an open-market sale. Following these transactions, he directly holds 10,140 Ordinary Shares, which include 65 shares acquired through dividend reinvestment since his last report.

Insider Trade Summary

2 transactions reported

Mixed 2 txns

Insider Lofton Kevin E

Role Director

Type	Security	Shares	Price	Value
Exercise Price or Tax Liability	Ordinary Shares	207	$81.90	$17K
Grant/Award	Ordinary Shares	2,111	$0.00	$0.00

Holdings After Transaction: Ordinary Shares — 10,140 shares (Direct)

Footnotes (3)

1. F1. Represents an award of restricted stock units that vest on the one-year anniversary of the award date.
2. F2. Includes 65 shares acquired through dividend reinvestment since the last report filed by the reporting person.
3. F3. Represents shares withheld for payment of taxes upon the vesting of restricted stock units previously reported on Table I.

Key Figures

RSU grant: 2,111 shares at $0.00 Tax-withholding shares: 207 shares at $81.90 Shares held after transactions: 10,140 Ordinary Shares +1 more

4 metrics

RSU grant 2,111 shares at $0.00 Restricted stock unit award on April 27, 2026

Tax-withholding shares 207 shares at $81.90 Shares withheld for taxes on April 28, 2026

Shares held after transactions 10,140 Ordinary Shares Direct holdings following reported Form 4 transactions

Dividend reinvestment shares 65 shares Acquired through dividend reinvestment since last report

Key Terms

restricted stock units, dividend reinvestment, tax-withholding disposition

3 terms

restricted stock units financial

"Represents an award of restricted stock units that vest on the one-year anniversary"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

dividend reinvestment financial

"Includes 65 shares acquired through dividend reinvestment since the last report"

Dividend reinvestment is when the money earned from a company's profit sharing, called dividends, is automatically used to buy more shares of that company instead of being received as cash. This process helps investors grow their holdings over time without extra effort, much like using earned interest to buy more of a savings account. It encourages long-term investment growth by continuously increasing the amount of shares owned.

tax-withholding disposition financial

"Represents shares withheld for payment of taxes upon the vesting of restricted stock units"

A tax-withholding disposition is an event or transaction—such as selling or transferring securities, exercising options, or receiving compensation—that triggers a requirement to hold back part of the payment and remit it to tax authorities. It matters to investors because it reduces the cash they receive immediately and can change the timing and amount of taxable income, like a cashier taking a portion of your sale proceeds to pay taxes before you get the rest.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Medtronic (MDT) director Kevin E. Lofton report in this Form 4?

Kevin E. Lofton reported an equity award and related tax withholding. He received 2,111 Medtronic Ordinary Shares as a restricted stock unit grant and had 207 shares withheld to cover taxes when earlier restricted stock units vested.

How many Medtronic (MDT) shares did Kevin Lofton acquire in the reported transactions?

He acquired 2,111 Ordinary Shares at $0.00 per share as a grant. These shares represent restricted stock units that will vest on the one-year anniversary of the award date, reflecting compensation rather than an open-market purchase.

Were any of Kevin Lofton’s Medtronic (MDT) transactions open-market sales or purchases?

No open-market trades were reported. The Form 4 shows a grant of 2,111 restricted stock units and withholding of 207 shares at $81.90 per share solely to pay tax obligations upon vesting of previously granted restricted stock units.

How many Medtronic (MDT) shares does Kevin Lofton hold after these Form 4 transactions?

After the reported transactions, Kevin Lofton directly holds 10,140 Medtronic Ordinary Shares. This total includes 65 shares that were acquired through dividend reinvestment since his previous ownership report filed with the SEC.

What is the significance of the 207 Medtronic (MDT) shares withheld at $81.90?

The 207 shares withheld at $81.90 per share were used to pay taxes when previously granted restricted stock units vested. This tax-withholding disposition does not represent an open-market sale, but a standard method of satisfying tax liabilities on equity compensation.

What are the vesting terms of Kevin Lofton’s new Medtronic (MDT) restricted stock unit award?

The new award of 2,111 restricted stock units vests on the one-year anniversary of the award date. Once vested, the units convert into Medtronic Ordinary Shares, reflecting time-based compensation for Kevin Lofton’s service as a director.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 04/29/2026 - 04:16 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Lofton Kevin E

(Last) (First) (Middle)

C/O MEDTRONIC

710 MEDTRONIC PARKWAY

(Street)

MINNEAPOLIS MINNESOTA 55432

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Medtronic plc [ MDT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
04/27/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Ordinary Shares	04/27/2026		A		2,111(1)	A	$0	10,347(2)	D
Ordinary Shares	04/28/2026		F		207(3)	D	$81.9	10,140	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents an award of restricted stock units that vest on the one-year anniversary of the award date.

2. Includes 65 shares acquired through dividend reinvestment since the last report filed by the reporting person.

3. Represents shares withheld for payment of taxes upon the vesting of restricted stock units previously reported on Table I.

Remarks:

	/s/ Patricia Walesiewicz, attorney-in-fact	04/29/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)